INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
KJ

Kihara James

PRINCIPAL ACCOUNTING OFFICERCIK 0001816160

EDGAR filingsOpen in network
Disclosed transactions16
Buys / sells0 / 6
Max Insider Score33
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
15
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$298K
11.4K sh
Jun 26, 2026Jun 29, 2026
traded Jun 26, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ACADIA PHARMACEUTICALS INCPRINCIPAL ACCOUNTING OFFICER · Nov 19, 2025
32
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale
SELL
$23K
1,030 sh
Apr 7, 2026
Apr 7, 2026
traded Apr 7, 2026
+0d
SEC FORM 4

Evidence

5
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
2,010 sh
Apr 5, 2026Apr 7, 2026
traded Apr 5, 2026
+2dSEC FORM 4

Evidence

9
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
2,010 sh
Apr 5, 2026Apr 7, 2026
traded Apr 5, 2026
+2dSEC FORM 4

Evidence

9
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
2,142 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC FORM 4

Evidence

13
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
1,627 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC FORM 4

Evidence

32
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale
SELL$24K
1,097 sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC FORM 4

Evidence

32
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale
SELL$261
12 sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC FORM 4

Evidence

32
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale
SELL$18K
833 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC FORM 4

Evidence

17
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
2,142 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC FORM 4

Evidence

9
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
1,627 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC FORM 4

Evidence

33
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Open-market sale
SELL$97K
4,084 sh
Nov 18, 2025Nov 19, 2025
traded Nov 18, 2025
+1dSEC FORM 4

Evidence

9
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
3,966 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

9
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
3,966 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

13
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
3,966 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence

13
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
3,966 sh
Nov 17, 2025Nov 19, 2025
traded Nov 17, 2025
+2dSEC FORM 4

Evidence